Dutch Cabinet Wants to Weigh Costs in Medical Treatment Guidelines

The Dutch cabinet wants to legally require that healthcare costs and collective health benefits are weighed in medical treatment guidelines compiled by doctors, nrc.nl reported.

Zorginstituut Nederland already assesses effective medical procedures on cost-effectiveness. The institute examines whether the costs of gaining a healthy life year stay below agreed limits.

That practice sometimes leads to effective but expensive medicines for cancer and rare diseases being excluded from the basic package. It also results in delays through prolonged research and negotiation.

The cabinet now aims to achieve maximum health gain for the population as a whole in exchange for public expenditures. André Knottnerus, an epidemiologist and emeritus professor of medicine at Maastricht University, raised concerns about this approach.

The requirement to factor costs and collective health benefits into medical guidelines can conflict with the doctor’s oath. That oath prioritizes the patient’s interest, even when dealing with chronic conditions.

“[The requirement] can clash with the artseneed. That puts the interest of the patient first, even if they have a chronic condition whose indicated treatment yields relatively few healthy, but for the patient equally essential, life years,” Knottnerus told nrc.nl.

Patients with diseases that have effective yet high-priced treatments risk receiving lower priority under the new rules. The Centre for Ethics and Health also warned against increasing healthcare inequalities through such measures.

Government intervention in medical guidelines risks undermining public trust. Patients might question whether their personal interests remain central to medical decision-making.

Individual and population interests align because everyone faces the risk of serious illness. A reliable healthcare system benefits society as a whole.

“Patients who have the misfortune of depending on high-priced treatments must not have a lesser chance of good care,” Knottnerus said in nrc.nl.

Professional organizations can factor efficiency into guidelines without compromising patient welfare. Removing ineffective or unsafe medical practices from guidelines could save the Central Planning Bureau (CPB) nearly 6 billion euros annually over time.

Conversely, treatments that are proven effective and cost-effective belong in the guidelines. Doctors can also select appropriate patient groups more sharply to avoid wasted resources.

Zorginstituut Nederland must clearly map out treatments that are effective but exceed standard costs. Those findings can serve as a starting point for further research and tariff negotiations.

A solidaire society values avoiding ethically problematic trade-offs that disadvantage specific patient groups. The government holds a constitutional responsibility to promote public health and treat people equally.

Substantial savings remain possible without damaging care quality through fraud reduction and prevention measures. Restricting new treatments has proven unfeasible, and those therapies often become cheaper over time through patent expirations and broader acceptance.

More on Dutch: Dutch Tax Plan Passes in House After D66 and CDA Deal With Opposition

What does Zorginstituut Nederland currently assess?

Zorginstituut Nederland assesses effective medical procedures on cost-effectiveness by checking if the cost of gaining a healthy life year stays below agreed limits, according to nrc.nl.

How much money could removing ineffective care save?

The Central Planning Bureau (CPB) said that removing medical interventions whose effectiveness and safety are inadequately supported could save nearly 6 billion euros per year on balance, nrc.nl reported.